Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.

Suppr

超能文献

作者信息

Cheng H C, Reavis O K, Grisar J M, Claxton G P, Weiner D L, Woodward J K

出版信息

Life Sci. 1980;27(25-26):2529-34. doi: 10.1016/0024-3205(80)90534-2.

DOI:10.1016/0024-3205(80)90534-2

PMID:6111723

Abstract

摘要

相似文献

Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.

Life Sci. 1980;27(25-26):2529-34. doi: 10.1016/0024-3205(80)90534-2.

Cardiovascular properties of medroxalol, a new antihypertensive drug.

J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):299-315. doi: 10.1097/00005344-198103000-00009.

Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A.

Clin Exp Hypertens A. 1984;6(3):659-84. doi: 10.3109/10641968409044029.

A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4.

Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).

J Pharmacol Exp Ther. 1986 Mar;236(3):776-83.

Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.

Pharmacology. 2004 Mar;70(3):140-51. doi: 10.1159/000074977.

Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).

Toxicon. 1996 May;34(5):541-54. doi: 10.1016/0041-0101(96)00012-8.

Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.

Arch Int Pharmacodyn Ther. 1983 Mar;262(1):132-49.

Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.

Arch Int Pharmacodyn Ther. 1984 Dec;272(2):256-63.

Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.

Methods Find Exp Clin Pharmacol. 1988 Sep;10(9):551-7.

引用本文的文献

Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.

Br J Clin Pharmacol. 1984 May;17(5):573-8. doi: 10.1111/j.1365-2125.1984.tb02392.x.

Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Eur J Clin Pharmacol. 1984;26(6):663-8. doi: 10.1007/BF00541922.

Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.

Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):295-302. doi: 10.1007/BF00172681.

Pharmacokinetics of (+)-rolipram and (-)-rolipram in healthy volunteers.

Eur J Clin Pharmacol. 1990;38(1):71-5. doi: 10.1007/BF00314807.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验